3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
14
Sarcoma
6
Genitourinary
3
Gastrointestinal
3
Other solid neoplasm
1
Myeloid
1
Gynecologic
1
Dermatologic
1
Conditions
Mesothelioma, Malignant
13
Retinoblastoma
9
Mesothelioma
9
Solid Tumor
7
Sarcoma
6
Pancreatic Neoplasms
6
Lung Neoplasms
6
Unspecified Childhood Solid Tumor, Protocol Specific
5
Unspecified Adult Solid Tumor, Protocol Specific
5
Solid Tumors
5
Carcinoma, Non-Small-Cell Lung
5
Ovarian Neoplasms
4
Wilms Tumor
3
Solid Tumor, Adult
3
Neuroblastoma
3
Colorectal Neoplasms
3
Advanced Solid Tumors
3
Advanced Solid Tumor
3
Thymoma
2
Stomach Neoplasms
2
Sarcoma, Ewing
2
Rhabdomyosarcoma
2
Osteosarcoma
2
Neoplasms
2
Neoplasm Metastasis
2
Kidney Neoplasms
2
Colonic Neoplasms
2
Cholangiocarcinoma
2
Carcinoma, Renal Cell
2
Breast Neoplasms
2
Interventions
Granulocyte Colony-Stimulating Factor
3
Etoposide
3
tazemetostat
2
Thiotepa
2
Mesna
2
Melphalan
2
Ifosfamide
2
Filgrastim
2
Carboplatin
2
Busulfan
2
sargramostim
1
pembrolizumab
1
pegylated granulocyte colony-stimulating factor
1
omburtamab I-131
1
etoposide phosphate
1
Ursodeoxycholic Acid
1
Topotecan
1
Stem Cell Transplantation
1
Sirolimus
1
Simvastatin
1
Rifampin
1
Radiotherapy, Intensity-Modulated
1
Radiation
1
Peripheral Blood Stem Cell Transplantation
1
Paclitaxel
1
Leukapheresis
1
Itraconazole
1
Immunologic Techniques
1
Cyclophosphamide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Rhabdoid Tumor
×
Cyclophosphamide
×
Other solid neoplasm
×
Clear all
NCT02390843
2020-04-03
AflacST1402
Emory University
Phase 1
Completed
13 enrolled